AESKUBLOTS ANA-17 Comp is used for the differential diagnosis of systemic rheumatic diseases. The detection of autoantibodies in AESKUBLOTS with the corresponding specific antigens allows an easier and more reliable differentiation of specific ANAs (anti-nuclear antibodies).
ANAs occur in active and inactive systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjogren"s syndrome, primary biliary cirrhosis (PBC) and polymyositis.
ANA-17 Comp antigens are fitted on the test strip according to their relevance for the individual autoimmune disease (SLE, Sjogren"s syndrome, CREST syndrome, scleroderma, MCTD, myositis, and PBC) for easier interpretation.The combination of two markers provides highest sensitivity and specificity for a MCTD.
U1 snRNP, snRNP/Sm, SmD1, PCNA, dsDNA, Rib-P0, nucleosomes, histones, SS-A/Ro60kD, SS-A/Ro52kD, SS-B/La, CENP-B, Scl-70, Jo-1, Pm-Scl, Mi-2 and Ku in human Serum.
AESKU.GROUP位于德国温德尔斯海姆,是一家致力于研究,提供创新和高效产品和服务的研究型供应商,用于早期发现,诊断和预后自身免疫性疾病。
自AESKU.DIAGNOSTICS于2000年成立以来仅十年,就在自身免疫领域广受认可,在全球90多个国家/地区推出了150多种产品以及不间断的服务。